Ngā hua rapu - Wan‐Fai Ng

Whakamahine hua
  1. 1
    Primary Sjogren's syndrome: too dry and too tired

    Primary Sjogren's syndrome: too dry and too tired mā Wan‐Fai Ng, Simon Bowman

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Autonomic Nervous System Dysfunction in Primary Sjögren’s Syndrome

    Autonomic Nervous System Dysfunction in Primary Sjögren’s Syndrome mā Kristen Davies, Wan‐Fai Ng

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  3. 3
    United Kingdom Primary Sjogren's Syndrome Registry--a united effort to tackle an orphan rheumatic disease

    United Kingdom Primary Sjogren's Syndrome Registry--a united effort to tackle an orphan rheumatic disease mā Wan‐Fai Ng, Simon Bowman, Bridget Griffiths

    I whakaputaina 2010
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  4. 4
    Dendritic Cells in Transplantation—Friend or Foe?

    Dendritic Cells in Transplantation—Friend or Foe? mā Robert I. Lechler, Wan‐Fai Ng, Ralph M. Steinman

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  5. 5
    Cardiovascular risk in juvenile idiopathic arthritis

    Cardiovascular risk in juvenile idiopathic arthritis mā Elizabeth J. Coulson, Wan‐Fai Ng, Iain Goff, Helen Foster

    I whakaputaina 2013
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  6. 6
    <p>Managing fatigue in patients with primary Sjögren’s syndrome: challenges and solutions</p>

    <p>Managing fatigue in patients with primary Sjögren’s syndrome: challenges and solutions</p> mā Samira Tatiyama Miyamoto, Dennis Lendrem, Wan‐Fai Ng, Katie L. Hackett, Valéria Valim

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  7. 7
    Fatigue in primary Sjögren’s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study

    Fatigue in primary Sjögren’s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study mā Kristen Davies, Kamran Mirza, Jessica Tarn, Nadia Howard-Tripp, Simon Bowman, Dennis Lendrem, Wan‐Fai Ng

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  8. 8
    Impaired functional status in primary Sjögren's syndrome

    Impaired functional status in primary Sjögren's syndrome mā Katie L. Hackett, Julia L. Newton, James Frith, Chris Elliott, Dennis Lendrem, H. Foggo, Suzanne Edgar, Sheryl Mitchell, Wan‐Fai Ng

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  9. 9
    Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells

    Human CD4+CD25+ cells: a naturally occurring population of regulatory T cells mā Wan‐Fai Ng, Phillip J. Duggan, Frédérique Ponchel, Giuseppe Matarese, Giovanna Lombardi, A. David Edwards, John D. Isaacs, Robert I. Lechler

    I whakaputaina 2001
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  10. 10
    Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren’s Syndrome: A Randomized Clinical Trial

    Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren’s Syndrome: A Randomized Clinical Trial mā James Posada, Saba Valadkhan, Daniel Burge, Kristen Davies, Jessica Tarn, John Casement, Kerry Jobling, Peter Gallagher, Douglas Wilson, Francesca Barone, Benjamin A. Fisher, Wan‐Fai Ng

    I whakaputaina 2020
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  11. 11
    OP0259-HPR Supervised walking improves aerobic capacity, exercise tolerance, fatigue and perceived improvement in women with primary sjÖgren's syndrome: a randomized controlled trial

    OP0259-HPR Supervised walking improves aerobic capacity, exercise tolerance, fatigue and perceived improvement in women with primary sjÖgren's syndrome: a randomized controlled tri... mā Samira Tatiyama Miyamoto, Valéria Valim, Luciana Carletti, Wan‐Fai Ng, R. Altoé, A.J. Perez, LH Dias, E.V. Serrano, AM Subtil, VB Cândido, Michael I. Trenell, Dennis Lendrem, Jamil Natour

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  12. 12
    The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome

    The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome mā Elizabeth Price, Saaeha Rauz, Anwar R. Tappuni, Nurhan Sutcliffe, Katie L. Hackett, Francesca Barone, Guido Granata, Wan‐Fai Ng, Benjamin A. Fisher, Stefano Bombardieri, Elisa Astorri, Ben Empson, Genevieve Larkin, Bridget Crampton, Simon Bowman

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Errata/Corrigenda
    Tiaki ki tētahi rārangi
    I tiakina i:
  13. 13
    The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome

    The British Society for Rheumatology guideline for the management of adults with primary Sjögren’s Syndrome mā Elizabeth Price, Saaeha Rauz, Anwar R. Tappuni, Nurhan Sutcliffe, Katie L. Hackett, Francesca Barone, Guido Granata, Wan‐Fai Ng, Benjamin A. Fisher, Stefano Bombardieri, Elisa Astorri, Ben Empson, Genevieve Larkin, Bridget Crampton, Simon Bowman

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  14. 14
    CD40 ligand antagonist dazodalibep in Sjögren’s disease: a randomized, double-blinded, placebo-controlled, phase 2 trial

    CD40 ligand antagonist dazodalibep in Sjögren’s disease: a randomized, double-blinded, placebo-controlled, phase 2 trial mā E. William St. Clair, Alan N. Baer, Wan‐Fai Ng, Ghaith Noaiseh, Chiara Baldini, Teresa K. Tarrant, Athena Papas, Valérie Devauchelle‐Pensec, Xue Wang, Wenjing Xu, Tuyet‐Hang Pham, Keith A. Sikora, William A. Rees, Ilias Alevizos

    I whakaputaina 2024
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  15. 15
    Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial

    Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial mā Arthur G. Pratt, Stefan Siebert, Michael Cole, Deborah Stocken, Christina Yap, Stephen Kelly, Muddassir Shaikh, Amy Cranston, Miranda Morton, Jenn Walker, Sheelagh Frame, Wan‐Fai Ng, Christopher D. Buckley, Iain B. McInnes, Andrew Filer, John D. Isaacs

    I whakaputaina 2021
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  16. 16
    Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

    Characterization of systemic disease in primary Sjögren’s syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements mā Manuel, Ramos-Casals, Pilar, Brito-Zerón, Raphaèle, Seror, Hendrika, Bootsma, Simon J, Bowman, Thomas, Dörner, Jacques-Eric, Gottenberg, Xavier, Mariette, Elke, Theander, Stefano, Bombardieri, Salvatore, De Vita, Thomas, Mandl, Wan-Fai, Ng, Aike, Kruize, Athanasios, Tzioufas, Claudio, Vitali

    I whakaputaina 2017
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Text
    Tiaki ki tētahi rārangi
    I tiakina i:
  17. 17
    Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements

    Characterization of systemic disease in primary Sjögren's syndrome: EULAR-SS Task Force recommendations for articular, cutaneous, pulmonary and renal involvements mā Manuel Ramos‐Casals, Pilar Brito‐Zerón, Raphaèle Séror, Hendrika Bootsma, Simon Bowman, Thomas Dörner, Jacques-Éric Gottenberg, Xavier Mariette, Elke Theander, Stefano Bombardieri, Salvatore De Vita, Thomas Mandl, Wan‐Fai Ng, Aike A. Kruize, Athanasios G. Tzioufas, Claudio Vitali

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:
  18. 18
    Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome

    Rheumatoid Factor and Disease Activity Are Independent Predictors of Lymphoma in Primary Sjögren's Syndrome mā Gaétane Nocturne, Alexandre Virone, Wan‐Fai Ng, Véronique Le Guern, É. Hachulla, Divi Cornec, C. Daïen, Olivier Vittecoq, Boris Bienvenu, Christian Marcelli, Daniel Wendling, Zahir Amoura, R. Dhôte, Christian Lavigne, R Fior, Jacques-Éric Gottenberg, Raphaèle Séror, Xavier Mariette

    I whakaputaina 2015
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  19. 19
    Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity

    Systemic interferon type I and type II signatures in primary Sjögren’s syndrome reveal differences in biological disease activity mā Iris L. A. Bodewes, Shereen Al-Ali, Cornelia G van Helden-Meeuwsen, Naomi I. Maria, Jessica Tarn, Dennis Lendrem, Marco W.J. Schreurs, Eline C. Steenwijk, Paul Van Daele, Tim Both, Simon Bowman, Bridget Griffiths, Wan‐Fai Ng, Marjan A. Versnel

    I whakaputaina 2018
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  20. 20
    Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren’s syndrome

    Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren’s syndrome mā Pilar Brito‐Zerón, Soledad Retamozo, Belchin Kostov, Chiara Baldini, Hendrika Bootsma, Salvatore De Vita, Thomas Dörner, Jacques‐Eric Gottenberg, Aike A. Kruize, Thomas Mandl, Wan‐Fai Ng, Raphaèle Séror, Athanasios G. Tzioufas, Claudio Vitali, Simon Bowman, Xavier Mariette, Manuel Ramos‐Casals

    I whakaputaina 2019
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Revisão
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: